The literature support that pregnant women with substance abuse who maintained on methadone, buprenorphine (Probuphine, Subutex) and buprenorphine and naloxone (Suboxone), exhibit improved compliance with prenatal care, improved newborn birth outcomes and reduced illicit drug use (Keegan et al., 2010).